Thursday, November 19, 2026 Vol. I · No. 7
Health · Via STAT

Merck, Isomorphic Labs partner to develop oncology drug candidates

Image: STAT

Merck and Isomorphic Labs said they are entering into a research collaboration to discover small molecule candidates in oncology.

This is a brief. The reporting belongs to STAT — read the complete story, with full context and credits, at the source.

Read the full story at STAT ↗

statnews.com

More from the Health desk